 | • レポートコード：MRC2-11QY00037 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はセリアック病治療薬のグローバル市場について調査・分析したレポートです。種類別（膨満、下痢、食欲不振、その他）市場規模、用途別（一次治療、二次治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別セリアック病治療薬の競争状況、市場シェア ・世界のセリアック病治療薬市場：種類別市場規模 2015年-2020年（膨満、下痢、食欲不振、その他） ・世界のセリアック病治療薬市場：種類別市場規模予測 2021年-2026年（膨満、下痢、食欲不振、その他） ・世界のセリアック病治療薬市場：用途別市場規模 2015年-2020年（一次治療、二次治療） ・世界のセリアック病治療薬市場：用途別市場規模予測 2021年-2026年（一次治療、二次治療） ・北米のセリアック病治療薬市場分析：米国、カナダ ・ヨーロッパのセリアック病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのセリアック病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のセリアック病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのセリアック病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F. Hoffmann-La Roche、Johnson & Johnson、Merck、Pfizer、ADMA Biologics、Amgen、Anthera Pharmaceuticals、Bayer、Biogen、BioLineRx、Biotest、Bristol-Myers Squibb、Celgene、Takeda Pharmaceutical、Novartis、LFB Group、Kedrion Biopharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Celiac Disease Drug Market
The global Celiac Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Celiac Disease Drug Scope and Market Size
Celiac Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Celiac Disease Drug market is segmented into
Distension
Diarrhea
Anorexia
Others
Segment by Application, the Celiac Disease Drug market is segmented into
First line of treatment
Second line of treatment
Regional and Country-level Analysis
The Celiac Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Celiac Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Celiac Disease Drug Market Share Analysis
Celiac Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Celiac Disease Drug business, the date to enter into the Celiac Disease Drug market, Celiac Disease Drug product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma
1 Study Coverage
1.1 Celiac Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Celiac Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Celiac Disease Drug Market Size Growth Rate by Type
1.4.2 Distension
1.4.3 Diarrhea
1.4.4 Anorexia
1.4.5 Others
1.5 Market by Application
1.5.1 Global Celiac Disease Drug Market Size Growth Rate by Application
1.5.2 First line of treatment
1.5.3 Second line of treatment
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Celiac Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Celiac Disease Drug Revenue 2015-2026
2.1.2 Global Celiac Disease Drug Sales 2015-2026
2.2 Global Celiac Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Celiac Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Celiac Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Celiac Disease Drug Competitor Landscape by Players
3.1 Celiac Disease Drug Sales by Manufacturers
3.1.1 Celiac Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Celiac Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Celiac Disease Drug Revenue by Manufacturers
3.2.1 Celiac Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Celiac Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Celiac Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Celiac Disease Drug Revenue in 2019
3.2.5 Global Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Celiac Disease Drug Price by Manufacturers
3.4 Celiac Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Celiac Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Celiac Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Celiac Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Celiac Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Celiac Disease Drug Sales by Type (2015-2020)
4.1.2 Global Celiac Disease Drug Revenue by Type (2015-2020)
4.1.3 Celiac Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Celiac Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Celiac Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Celiac Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Celiac Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Celiac Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Celiac Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Celiac Disease Drug Sales by Application (2015-2020)
5.1.2 Global Celiac Disease Drug Revenue by Application (2015-2020)
5.1.3 Celiac Disease Drug Price by Application (2015-2020)
5.2 Celiac Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Celiac Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Celiac Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Celiac Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Celiac Disease Drug by Country
6.1.1 North America Celiac Disease Drug Sales by Country
6.1.2 North America Celiac Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Celiac Disease Drug Market Facts & Figures by Type
6.3 North America Celiac Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Celiac Disease Drug by Country
7.1.1 Europe Celiac Disease Drug Sales by Country
7.1.2 Europe Celiac Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Celiac Disease Drug Market Facts & Figures by Type
7.3 Europe Celiac Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Celiac Disease Drug by Region
8.1.1 Asia Pacific Celiac Disease Drug Sales by Region
8.1.2 Asia Pacific Celiac Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Celiac Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Celiac Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Celiac Disease Drug by Country
9.1.1 Latin America Celiac Disease Drug Sales by Country
9.1.2 Latin America Celiac Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Celiac Disease Drug Market Facts & Figures by Type
9.3 Central & South America Celiac Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Celiac Disease Drug by Country
10.1.1 Middle East and Africa Celiac Disease Drug Sales by Country
10.1.2 Middle East and Africa Celiac Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Celiac Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Celiac Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description and Business Overview
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Celiac Disease Drug Products Offered
11.2.5 Johnson & Johnson Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Celiac Disease Drug Products Offered
11.3.5 Merck Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Celiac Disease Drug Products Offered
11.4.5 Pfizer Related Developments
11.5 ADMA Biologics
11.5.1 ADMA Biologics Corporation Information
11.5.2 ADMA Biologics Description and Business Overview
11.5.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ADMA Biologics Celiac Disease Drug Products Offered
11.5.5 ADMA Biologics Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Description and Business Overview
11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amgen Celiac Disease Drug Products Offered
11.6.5 Amgen Related Developments
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Corporation Information
11.7.2 Anthera Pharmaceuticals Description and Business Overview
11.7.3 Anthera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Anthera Pharmaceuticals Celiac Disease Drug Products Offered
11.7.5 Anthera Pharmaceuticals Related Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Description and Business Overview
11.8.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bayer Celiac Disease Drug Products Offered
11.8.5 Bayer Related Developments
11.9 Biogen
11.9.1 Biogen Corporation Information
11.9.2 Biogen Description and Business Overview
11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biogen Celiac Disease Drug Products Offered
11.9.5 Biogen Related Developments
11.10 BioLineRx
11.10.1 BioLineRx Corporation Information
11.10.2 BioLineRx Description and Business Overview
11.10.3 BioLineRx Sales, Revenue and Gross Margin (2015-2020)
11.10.4 BioLineRx Celiac Disease Drug Products Offered
11.10.5 BioLineRx Related Developments
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Description and Business Overview
11.1.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products Offered
11.1.5 F. Hoffmann-La Roche Related Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Corporation Information
11.12.2 Bristol-Myers Squibb Description and Business Overview
11.12.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bristol-Myers Squibb Products Offered
11.12.5 Bristol-Myers Squibb Related Developments
11.13 Celgene
11.13.1 Celgene Corporation Information
11.13.2 Celgene Description and Business Overview
11.13.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Celgene Products Offered
11.13.5 Celgene Related Developments
11.14 Takeda Pharmaceutical
11.14.1 Takeda Pharmaceutical Corporation Information
11.14.2 Takeda Pharmaceutical Description and Business Overview
11.14.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Takeda Pharmaceutical Products Offered
11.14.5 Takeda Pharmaceutical Related Developments
11.15 Novartis
11.15.1 Novartis Corporation Information
11.15.2 Novartis Description and Business Overview
11.15.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Novartis Products Offered
11.15.5 Novartis Related Developments
11.16 LFB Group
11.16.1 LFB Group Corporation Information
11.16.2 LFB Group Description and Business Overview
11.16.3 LFB Group Sales, Revenue and Gross Margin (2015-2020)
11.16.4 LFB Group Products Offered
11.16.5 LFB Group Related Developments
11.17 Kedrion Biopharma
11.17.1 Kedrion Biopharma Corporation Information
11.17.2 Kedrion Biopharma Description and Business Overview
11.17.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Kedrion Biopharma Products Offered
11.17.5 Kedrion Biopharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Celiac Disease Drug Market Estimates and Projections by Region
12.1.1 Global Celiac Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Celiac Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Celiac Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Celiac Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Celiac Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Celiac Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Celiac Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Celiac Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Celiac Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Celiac Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Celiac Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Celiac Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Celiac Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Celiac Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Celiac Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Celiac Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Celiac Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Celiac Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Celiac Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Celiac Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Celiac Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Celiac Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Celiac Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Celiac Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Celiac Disease Drug Market Segments
Table 2. Ranking of Global Top Celiac Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Celiac Disease Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Distension
Table 5. Major Manufacturers of Diarrhea
Table 6. Major Manufacturers of Anorexia
Table 7. Major Manufacturers of Others
Table 8. Global Celiac Disease Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Celiac Disease Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Celiac Disease Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Celiac Disease Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Celiac Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Celiac Disease Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Celiac Disease Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Celiac Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Celiac Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease Drug as of 2019)
Table 17. Celiac Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Celiac Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Celiac Disease Drug Price (2015-2020) (USD/Pcs)
Table 20. Celiac Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Celiac Disease Drug Product Type
Table 22. Date of International Manufacturers Enter into Celiac Disease Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Celiac Disease Drug Sales Share by Type (2015-2020)
Table 26. Global Celiac Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Celiac Disease Drug Revenue Share by Type (2015-2020)
Table 28. Celiac Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Celiac Disease Drug Sales Share by Application (2015-2020)
Table 31. North America Celiac Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Celiac Disease Drug Sales Market Share by Country (2015-2020)
Table 33. North America Celiac Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Celiac Disease Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Celiac Disease Drug Sales Market Share by Type (2015-2020)
Table 37. North America Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Celiac Disease Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Celiac Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Celiac Disease Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Celiac Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Celiac Disease Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Celiac Disease Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Celiac Disease Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Celiac Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Celiac Disease Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Celiac Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Celiac Disease Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Celiac Disease Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Celiac Disease Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Celiac Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Celiac Disease Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Celiac Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Celiac Disease Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Celiac Disease Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Celiac Disease Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Celiac Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Celiac Disease Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Celiac Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Celiac Disease Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Celiac Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Celiac Disease Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Celiac Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Celiac Disease Drug Sales Market Share by Application (2015-2020)
Table 71. F. Hoffmann-La Roche Corporation Information
Table 72. F. Hoffmann-La Roche Description and Major Businesses
Table 73. F. Hoffmann-La Roche Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. F. Hoffmann-La Roche Product
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. ADMA Biologics Corporation Information
Table 92. ADMA Biologics Description and Major Businesses
Table 93. ADMA Biologics Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. ADMA Biologics Product
Table 95. ADMA Biologics Recent Development
Table 96. Amgen Corporation Information
Table 97. Amgen Description and Major Businesses
Table 98. Amgen Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Amgen Product
Table 100. Amgen Recent Development
Table 101. Anthera Pharmaceuticals Corporation Information
Table 102. Anthera Pharmaceuticals Description and Major Businesses
Table 103. Anthera Pharmaceuticals Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Anthera Pharmaceuticals Product
Table 105. Anthera Pharmaceuticals Recent Development
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Major Businesses
Table 108. Bayer Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Bayer Product
Table 110. Bayer Recent Development
Table 111. Biogen Corporation Information
Table 112. Biogen Description and Major Businesses
Table 113. Biogen Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Biogen Product
Table 115. Biogen Recent Development
Table 116. BioLineRx Corporation Information
Table 117. BioLineRx Description and Major Businesses
Table 118. BioLineRx Celiac Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. BioLineRx Product
Table 120. BioLineRx Recent Development
Table 121. Biotest Corporation Information
Table 122. Biotest Description and Major Businesses
Table 123. Biotest Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Biotest Product
Table 125. Biotest Recent Development
Table 126. Bristol-Myers Squibb Corporation Information
Table 127. Bristol-Myers Squibb Description and Major Businesses
Table 128. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Bristol-Myers Squibb Product
Table 130. Bristol-Myers Squibb Recent Development
Table 131. Celgene Corporation Information
Table 132. Celgene Description and Major Businesses
Table 133. Celgene Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 134. Celgene Product
Table 135. Celgene Recent Development
Table 136. Takeda Pharmaceutical Corporation Information
Table 137. Takeda Pharmaceutical Description and Major Businesses
Table 138. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 139. Takeda Pharmaceutical Product
Table 140. Takeda Pharmaceutical Recent Development
Table 141. Novartis Corporation Information
Table 142. Novartis Description and Major Businesses
Table 143. Novartis Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 144. Novartis Product
Table 145. Novartis Recent Development
Table 146. LFB Group Corporation Information
Table 147. LFB Group Description and Major Businesses
Table 148. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 149. LFB Group Product
Table 150. LFB Group Recent Development
Table 151. Kedrion Biopharma Corporation Information
Table 152. Kedrion Biopharma Description and Major Businesses
Table 153. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 154. Kedrion Biopharma Product
Table 155. Kedrion Biopharma Recent Development
Table 156. Global Celiac Disease Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 157. Global Celiac Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 158. Global Celiac Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 159. Global Celiac Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 160. North America: Celiac Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 161. North America: Celiac Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Europe: Celiac Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 163. Europe: Celiac Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Asia Pacific: Celiac Disease Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 165. Asia Pacific: Celiac Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 166. Latin America: Celiac Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 167. Latin America: Celiac Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Middle East and Africa: Celiac Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 169. Middle East and Africa: Celiac Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 171. Key Challenges
Table 172. Market Risks
Table 173. Main Points Interviewed from Key Celiac Disease Drug Players
Table 174. Celiac Disease Drug Customers List
Table 175. Celiac Disease Drug Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Disease Drug Product Picture
Figure 2. Global Celiac Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Distension Product Picture
Figure 4. Diarrhea Product Picture
Figure 5. Anorexia Product Picture
Figure 6. Others Product Picture
Figure 7. Global Celiac Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 8. First line of treatment
Figure 9. Second line of treatment
Figure 10. Celiac Disease Drug Report Years Considered
Figure 11. Global Celiac Disease Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Celiac Disease Drug Sales 2015-2026 (K Pcs)
Figure 13. Global Celiac Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Celiac Disease Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Celiac Disease Drug Sales Market Share by Region in 2019
Figure 16. Global Celiac Disease Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Celiac Disease Drug Revenue Market Share by Region in 2019
Figure 18. Global Celiac Disease Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Celiac Disease Drug Revenue in 2019
Figure 20. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Celiac Disease Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Celiac Disease Drug Sales Market Share by Type in 2019
Figure 23. Global Celiac Disease Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Celiac Disease Drug Revenue Market Share by Type in 2019
Figure 25. Global Celiac Disease Drug Market Share by Price Range (2015-2020)
Figure 26. Global Celiac Disease Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Celiac Disease Drug Sales Market Share by Application in 2019
Figure 28. Global Celiac Disease Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Celiac Disease Drug Revenue Market Share by Application in 2019
Figure 30. North America Celiac Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Celiac Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Celiac Disease Drug Sales Market Share by Country in 2019
Figure 33. North America Celiac Disease Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Celiac Disease Drug Market Share by Type in 2019
Figure 39. North America Celiac Disease Drug Market Share by Application in 2019
Figure 40. Europe Celiac Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Celiac Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Celiac Disease Drug Sales Market Share by Country in 2019
Figure 43. Europe Celiac Disease Drug Revenue Market Share by Country in 2019
Figure 44. Germany Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Celiac Disease Drug Market Share by Type in 2019
Figure 55. Europe Celiac Disease Drug Market Share by Application in 2019
Figure 56. Asia Pacific Celiac Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Celiac Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Celiac Disease Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Celiac Disease Drug Revenue Market Share by Region in 2019
Figure 60. China Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Celiac Disease Drug Market Share by Type in 2019
Figure 83. Asia Pacific Celiac Disease Drug Market Share by Application in 2019
Figure 84. Latin America Celiac Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Celiac Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Celiac Disease Drug Sales Market Share by Country in 2019
Figure 87. Latin America Celiac Disease Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Celiac Disease Drug Market Share by Type in 2019
Figure 95. Latin America Celiac Disease Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Celiac Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Celiac Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Celiac Disease Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Celiac Disease Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Celiac Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Celiac Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Celiac Disease Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Celiac Disease Drug Market Share by Application in 2019
Figure 108. North America Celiac Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Celiac Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Celiac Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Celiac Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Celiac Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Celiac Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Celiac Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Celiac Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Celiac Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Celiac Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
セリアック病の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Market The global Celiac Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Scope and Market Size Celiac Disease market is segmented by Type, and …- セリアック治療薬の世界市場（～2026年） Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine…
- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…